Measuring the Effects of Rhopressa on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects

NCT04401982 · clinicaltrials.gov ↗

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Ocular Hypertension
Suspect Glaucoma

Interventions

DRUG: Netarsudil ophthalmic solution 0.02% one drop nightly for 1-2 weeks

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]